# Randomized Controlled Trial of Trastuzumab With or Without Chemotherapy for HER2-Positive Early Breast Cancer in Older Patients

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/randomized-controlled-trial-of-trastuzumab-with-or-without-chemotherapy-for-her2/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Masataka Sawaki,Naruto Taira,Yukari Uemura,Tsuyoshi Saito,Shinichi Baba,Kokoro Kobayashi,Hiroaki Kawashima,Michiko Tsuneizumi,Noriko Sagawa,Hiroko Bando,Masato Takahashi,Miki Yamaguchi,Tsutomu Takashima,Takahiro Nakayama,Masahiro Kashiwaba,Toshiro Mizuno,Yutaka Yamamoto,Hiroji Iwata,Takuya Kawahara,Yasuo Ohashi,Hirofumi Mukai,for the RESPECT study group |
| Citations | 87 |
| DOI | 10.1200/jco.20.00184 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.20.00184 |
| OpenAlex ID | https://openalex.org/W3085262751 |
| PMID | 32936713 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Takuya Kawahara](https://scholariq.org/researchers/takuya-kawahara/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Breast Lesions and Carcinomas](https://scholariq.org/topics/breast-lesions-and-carcinomas/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.